Julie Vaughn, MD
Internal Medicine · Towson, MDNPI 1932177201
Payments from drug & device makers
Across 52 payments — averaging $16.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$167
- AstraZeneca$145
- Novo Nordisk$133
- Lilly USA, LLC$118
- Amgen$45
- Esperion Therapeutics, Inc.$42
- plus $189 from 9 others
What the payments were for
- Food & beverage$840100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 11 | $167 |
| AstraZeneca(2 entities) | 9 | $145 |
| Novo Nordisk | 8 | $133 |
| Lilly USA, LLC | 7 | $118 |
| Amgen | 3 | $45 |
| Esperion Therapeutics, Inc. | 3 | $42 |
| Exact Sciences | 1 | $34 |
| Boehringer Ingelheim | 2 | $29 |
| Pfizer | 2 | $28 |
| Assertio Therapeutics, Inc. | 1 | $20 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $17 |
| Dynavax Technologies Corporation | 1 | $16 |
| Novartis | 1 | $16 |
| Merck | 1 | $12 |
How this compares
$840 in reported general payments places this provider in the 70th percentile of 2,979 internal medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Losartan Potassium | 41 | $628 |
| Amlodipine Besylate | 68 | $492 |
| Pravastatin Sodium | 29 | $476 |
| Rosuvastatin Calcium | 30 | $456 |
| Atorvastatin Calcium | 39 | $429 |
| Metoprolol Succinate | 16 | $316 |
| Gabapentin | 13 | $263 |
| Pantoprazole Sodium | 11 | $238 |
| Metformin Hcl | 27 | $229 |
| Levothyroxine Sodium | 22 | $172 |
| Hydrochlorothiazide | 34 | $156 |
| Lisinopril | 11 | $145 |
| Potassium Chloride | 14 | $130 |
| Simvastatin | 13 | $114 |
| Warfarin Sodium | 11 | $113 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Towson
- Gregory PokrywkaTowson$410K
- Shishir KhetanRockville$52.1M
- Steven GellerElkridge$15.1M
- Mary HowellHagerstown$6.2M
- Kristen MarroneBaltimore$5.6M
- Jonathan CohenRockville$5M
- Andrea ApoloBethesda$4.8M
- Peta-Gay Jackson BoothBaltimore$3.6M
- Rahul PatelRockville$2.8M
- Mark YarchoanBaltimore$2.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.